Arrowstreet Capital, Limited Partnership Repligen Corp Transaction History

Arrowstreet Capital, Limited Partnership

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$161.19 - $257.96 $23.3 Million - $37.3 Million	-144,517 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $12.2 Million - $15 Million	-49,322 Reduced 25.44%	144,517 $38.3 Million
Q3 2021 Nov 12, 2021	SELL	$194.77 - $324.21 $2.81 Million - $4.68 Million	-14,449 Reduced 6.94%	193,839 $56 Million
Q2 2021 Aug 13, 2021	SELL	$165.87 - $220.95 $7.2 Million - $9.59 Million	-43,383 Reduced 17.24%	208,288 $41.6 Million
Q1 2021 May 14, 2021	SELL	$180.37 - $226.26 $10.9 Million - $13.7 Million	-60,329 Reduced 19.34%	251,671 $48.9 Million
Q4 2020 Feb 12, 2021	BUY	$148.08 - $206.57 $10.1 Million - $14.2 Million	68,522 Added 28.14%	312,000 $59.8 Million
Q3 2020 Nov 12, 2020	BUY	$122.51 - $158.27 $19.1 Million - $24.7 Million	156,283 Added 179.23%	243,478 $35.9 Million
Q2 2020 Aug 12, 2020	BUY	$94.33 - $140.48 $8.23 Million - $12.2 Million	87,195 New	87,195 $10.8 Million
Q3 2019 Nov 14, 2019	SELL	$76.65 - $95.51 $909,375 - $1.13 Million	-11,864 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$54.2 - $85.95 $2.01 Million - $3.19 Million	-37,133 Reduced 75.79%	11,864 $1.02 Million
Q1 2019 May 15, 2019	BUY	$49.45 - $62.8 $2.42 Million - $3.08 Million	48,997 New	48,997 $2.9 Million

476

54.5M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.87B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.